Condition: Herpes Zoster · Sponsor: ModernaTX, Inc.
The purpose of this first-in-human study is to evaluate the safety and immunogenicity of mRNA-1468.
This description comes directly from the study's public registry record.
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
| Velocity Clinical Research - Westlake | Los Angeles, California, United States | — |
| Tekton Research, Inc - Longmont Center | Longmont, Colorado, United States | — |
| Meridien Research | Lakeland, Florida, United States | — |
| Clinical Trials of Florida, LLC | Miami, Florida, United States | — |
| Floridian Clinical Research | Miami Lakes, Florida, United States | — |
| Florida Pulmonary Research Institute, LLC | Winter Park, Florida, United States | — |
| Centricity Research | Columbus, Georgia, United States | — |
| Great Lakes | Chicago, Illinois, United States | — |
| DM Clinical Research- River Forest | River Forest, Illinois, United States | — |
| Meridian Clinical Research - Dakota Dunes | Sioux City, Iowa, United States | — |
| Johnson County Clin-Trials (JCCT) | Lenexa, Kansas, United States | — |
| NOLA Research Works | New Orleans, Louisiana, United States | — |
+ 8 more locations — full list on the registry record.
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.